KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Profit After Tax (2017 - 2025)

Historic Profit After Tax for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $18.1 million.

  • Amneal Pharmaceuticals' Profit After Tax rose 5422.3% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.3 million, marking a year-over-year increase of 15771.37%. This contributed to the annual value of -$73.9 million for FY2024, which is 5162.76% down from last year.
  • As of Q3 2025, Amneal Pharmaceuticals' Profit After Tax stood at $18.1 million, which was up 5422.3% from $35.6 million recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Profit After Tax ranged from a high of $35.6 million in Q2 2025 and a low of -$242.1 million during Q2 2022
  • Moreover, its 5-year median value for Profit After Tax was $11.8 million (2024), whereas its average is -$13.6 million.
  • Within the past 5 years, the most significant YoY rise in Amneal Pharmaceuticals' Profit After Tax was 42881.91% (2023), while the steepest drop was 257662.51% (2023).
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Profit After Tax stood at -$20.5 million in 2021, then soared by 118.42% to $3.8 million in 2022, then crashed by 2576.63% to -$93.3 million in 2023, then skyrocketed by 112.78% to $11.9 million in 2024, then soared by 52.0% to $18.1 million in 2025.
  • Its Profit After Tax stands at $18.1 million for Q3 2025, versus $35.6 million for Q2 2025 and $24.6 million for Q1 2025.